In vitro, this complex could suppress Her2+ breast cancer cell lines and primary human cancer cells by targeted gene expression inhibition, reducing proliferation and increasing apoptosis of Her2+ breast cancer cell lines. Here, ERBB2 is linked to breast carcinoma.